3. Należy podkreślić, że właściwa opieka medyczna nad pacjentką z nowotworem złośliwym narządu płciowego oraz wykonanie doszczętnego zabiegu operacyjnego, zgodnie z dostępną literaturą, istotnie wydłuża długość życia pacjentek.

ABSTRACT

The role and range of pelvic and paraaortic lymphadenectomy in gynaecological malignancies has been widely discussed for several years. Lymph node dissection is now an integral part of surgical treatment in gynaecological oncology. The surgical outcome depends on patient characteristics, stage of the disease and tumour resectability status. The prognostic value of cytoreductive surgery has been reported in several meta-analyses. Systemic lymphadenectomy is of relevance not only for proper clinical staging but also for selecting appropriate adjuvant therapy. Moreover, it is reported that patients with lymphadenectomy and macroscopically complete intraperitoneal debulking (no gross residual disease - NGR) have a better prognosis and that lymph node dissection has a positive impact on overall survival (OS) and progression-free survival (PFS). This article reviews the literature and current recommendations concerning pelvic and paraaortic lymph node dissection in different types of gynaecologic malignancies.


Keywords: lymphadenectomy, gynaecologic oncology, metastases.

Zdjęcia – prof. dr. hab. med. Andrzeja Witka, dr. n. med. Wojciecha Szaneckiego, lek. Agnieszki Wróblewskiej-Czech – archiwum prywatne, ryciny – lek. Agnieszka Wróblewska-Czech (7)

Piśmiennictwo

1. Seamon lG, Richardson DL, Copeland LJ. Evolution of the Gynecologic Oncology Group protocols in treatment of epithelial ovarian cancer. Clin. Obstet. Gynecol. 2012;55:131-55

2. du Bois A, Reuss A, Harter P et al. Potential role of lymphadenectomy in advanced ovarian cancer: a combined exploratory analysis of three prospectively randomized phase III multicenter trials. J. Clin. Oncol. 2012;125:1733-9

3. Ramondetta L. Lymphatic anatomy and physiology, Op Tech Gyn Surg, 6:2001

4. Bochenek A, Reicher M. Anatomia człowieka. Tom III. Warszawa: PZWL, 2014

5. Wicherek Ł, Kojs Z, Bręborowicz GH (eds). Ginekologia onkologiczna. Warszawa: PZWL, 2017

6. Cibula D, Abu-Rustum N. Pelvic lymphadenectomy in cervical cancer-surgical anatomy and proposal for a new classification system, Gynecol Oncol.2010;116:33-7

7. Bidziński M, Rzepka J, Dańska-Bidzińska A, Góźdź S. Rola oznaczania węzła wartowniczego w nowotworach narządów płciowych u kobiet. Borgis – Postępy Nauk Medycznych. 2013:488-91

8. du Bois A, Reuss A, Harter P, Pujade-Lauraine E, Ray-Coquard I, Pfisterer J. Potential role of lymphadenectomy in advanced ovarian cancer. A combined exploratory analysis of three prospectively Randomized phase III multicenter trials. Journal of clinical oncology, 2010;28:1733-9

9. Takeshima N, Hirai Y, Umayahara K, Fujiwara K, Takizawa K, Hasumi K. Lymph node metastasis in ovarian cancer: difference between serous and non-serous primary tumors. Gynecologic oncology,2005;99:427-31

10. Morice P, Joulie F, Camatte S et al. Lymph node involvement in epithelial ovarian cancer: Analysis of 276 pelvic and paraaortic lymphadenectomies and surgical implications. J Am Coll Surg, 2003;197:198-205

11. Panici BP, Maggione A, Hacker N et al. Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes only in optimally debulked advanced ovarian cancer: A randomized clinical trial. J Natl Cancer Inst, 2005;97:560-6

12. Eoh KJ, Lee J, Yoon J, Nam E, Kim S, Kim SW, Kim Y. Role of systematic lymphadenectomy as part of primary debulking surgery for optimally cytoreduced advanced ovarian cancer: Reappraisal in the era of radical surgery. Oncotarget, 2017;8:37807-16

13. Maggioni A, Benedetti Panici P, Dell’Anna T, Landoni F, Lissoni A, Pellegrino A, Rossi RS, Chiari S, Campagnutta E, Greggi S, Angioli R, Manci N, Calcagno M, et al. Randomised study of systematic lymphadenectomy In patients with epithelial ovarian cancer macroscopically confined to the pelvis. Br J Cancer.2016;95:699-704

14. NCCN Clinical Practice Guidelines in Oncology. National Comprehensive Cancer Network 2016 Dostępne na stronie: https://www.nccn.org/professionals/physician_gls/f_guidelines.asp

15. Chan JK, Munro EG, Cheung MK, Husain A, et al. Association of lymphadenectomy and survival in stage I ovarian cancer patients. ObstetGynecol, 2007;109:12-9

16. Wojciechowska U, Didkowska J. Zachorowania i zgony na nowotwory złośliwe w Polsce. Krajowy Rejestr Nowotworów, Centrum Onkologii – Instytut im. Marii Skłodowskiej-Curie. Dostępne na stronie http://onkologia.org.pl/raporty/ dostęp z dnia 24/07/2017

17. Höckel M, Horn LC, Tetsch E, Einenkel J. Pattern analysis of regional spread and therapeutic lymph node dissection in cervical cancer based on ontogenetic anatomy. Gynecol Oncol. 2012;125(1):168-74

18. Choi HJ, Ju W, Myung SK, Kim Y. Diagnostic performance of computer tomography, magnetic resonance imaging, and positron emission tomography or positron emission tomography/computer tomography for detection of metastatic lymph nodes in patients with cervical cancer: meta-analysis. Cancer science 2010;11:1471-9

19. Fuller AF, Elliott N, Kosloff C, et al. Determinants of increased risk for recurrence in patients undergoing radical hysterectomy for stage IB and IIA carcinoma of the cervix. Gynecol Oncol. 1989;33(1):34-9

20. Bast A, Clement D, Laurousserie F et al. Sentinel lymph node biopsy improves staging in early cervical cancer. Gyn Oncol 2007;105:187-93

21. Wydra D et al. Identyfikacja węzła wartowniczego w inwazyjnym raku szyjki macicy – Rak szyjki macicy. Wybierz życie. Oddział Gdański PTG Gdańsk 2007

22. Lécuru F, Mathevet P, Querleu D et al. Bilateral negative sentinel nodes accurately predict absence of lymph node metastasis in early cervical cancer: results of the SENTICOL study. J Clin Oncol 2011;29(13):1686-91

23. Colombo N, Creutzberg C, Amant F, Bosse T et al. ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up. Ann Oncol. 2016 Jan;27(1):16-41

24. Kim HS, Suh DH, Kim MK et al. Systematic lymphadenectomy for survival in patients with endometrial cancer: a meta-analysis. Jpn J Clin Oncol 2012;42:405-12

25. Markowsja J, Mądry R (eds). Zarys Ginekologii onkologicznej. Poznań, Polska: Tramedia; 2015

26. Mariani A, Dowdy SC, Cliby WA. Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging, Gynecol. Oncol. 2008;109:11-8

27. Boren T, Lea J, Kehoe S. Lymph node metastasis in endometrioid adenocarcinomas of the uterine corpus with occult cervical involvement. Gynecol. Oncol. 2012;127:43-6

28. Darai E, Dubernard G, Bats AS, Heitz D et al. Sentinel node biopsy for the management of early stage endometrial cancer: long-term results of the SENTI-ENDO study. Gynecol Oncol. 2015;136(1):54-9

29. Kitchener H, Swart AM, Qian Q. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet 2009;373:125-36

30. Benedetti Panici P, Basile S, Maneschi F. Systematic pelvic lymphadenectomy vs no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J. Natl. Cancer Inst. 2008;100:1707-16

31. Coronado PJ, Fasero M, Baquedano L. Impact of the lymphadenectomy in high-risk histologic types of endometrial cancer: a matched-pair study. Int. J. Gynecol. Cancer 2014;24:703-12

32. Naumann RW. The role of lymphadenectomy in endometrial cancer: was the ASTEC trial doomed by design and are we destined to repeat that mistake? Gynecol Oncol 2012;126:5-11

33. Smith DC, Macdonald OK, Lee CM, Gaffney DK. Survival impact of lymph node dissection in endometrial adenocarcinoma: a surveillance, epidemiology, and end results analysis. Int J Gynecol Cancer 2008;18:255-61

34. Frumovitz M, Singh DK, Meyer L. Predictors of final histology in patients with endometrial cancer. Gynecol. Oncol. 2004;95:463-8

35. Senn B, Mueller MD, Cignacco EL et al. Period prevalence and risk factors for postoperative short-term wound complications in vulvar cancer: a cross-sectional study. Int J Gynecol Cancer 2010;20(4):646-54

36. Gaarenstroom K, Kenter G, Trimbos J et al. Postoperative complications after vulvectomy and inguinofemoral lymphadenectomy using separate groin incisions. Int J Gynecol Cancer 2003;13(4):522-7

37. Johann S, Klaeser B, Krause T et al. Comparison of outcome and recurrence-free survival after sentinel lymph node biopsy and lymphadenectomy in vulvar caner. Gynecol Oncol 2008;110(3):324-8

38. Hampl M, Hantschmann P, Michels W et al. Validation of the accuracy of the sentinel lymph node procedure in patients with vulvar cancer: results of a multicenter study in Germany. Gynecol Oncol 2008;111(2):282-8

39. Oonk M, van Hemel B, Hollema H. Size of sentinel-node metastasis and chances of non-sentinel-node involvement and survival in early stage vulvar cancer: results from GROINSS-V, a multicentre observational study. Lancet Oncol 2010;11(7):646-52

Do góry